Literature DB >> 22790125

Prevalence of pulmonary arteriovenous malformations as estimated by low-dose thoracic CT screening.

Masayuki Nakayama1, Takeshi Nawa, Tatsuya Chonan, Katsuyuki Endo, Satoshi Morikawa, Masashi Bando, Yasuhiko Wada, Takanobu Shioya, Yukihiko Sugiyama, Shimao Fukai.   

Abstract

BACKGROUND: Pulmonary arteriovenous malformations (PAVMs) are rarely encountered in clinical practice. The prevalence of PAVMs associated with hereditary hemorrhagic telangiectasia (HHT) has been estimated based on the rate in the family members of HHT patients, but the prevalence of PAVMs in the general population remains unknown.
METHODS: We retrospectively examined the prevalence and clinical characteristics of PAVMs as detected by a low-dose thoracic CT screening program for lung cancer at the Hitachi Medical Center and the Hitachi General Health Care Center in the northern part of Ibaraki Prefecture, Japan.
RESULTS: From 2001 to 2007, we identified eight patients (seven females and one male) with PAVMs among 21,235 initial screening participants (the mean age of the patients with PAVMs and that of the screening participants was 60.6 years). The prevalence of PAVMs was estimated at 38 per 100,000 individuals [95% confidence interval (CI)=18-76]. The diameter of the PAVMs was a mean of 6.6 mm, and none of the lesions could be detected by chest X-ray. Females older than 60 years tended to have larger PAVMs than younger women did (p=0.06). Two patients (25%) were diagnosed with HHT. One patient had previously undergone surgery for a brain abscess.
CONCLUSION: PAVMs are more prevalent than previously reported, especially among females.

Entities:  

Mesh:

Year:  2012        PMID: 22790125     DOI: 10.2169/internalmedicine.51.7305

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  28 in total

Review 1.  Contemporary Management of Pulmonary Arteriovenous Malformations.

Authors:  Nicholas Rauh; John Gurley; Sibu Saha
Journal:  Int J Angiol       Date:  2017-09-18

2.  Expansion of pulmonary arteriovenous malformations after grand mal seizures and other circumstances of PAVM growth.

Authors:  Ami Schattner; Ina Dubin
Journal:  BMJ Case Rep       Date:  2019-08-10

Review 3.  Pulmonary arteriovenous malformations.

Authors:  Claire L Shovlin
Journal:  Am J Respir Crit Care Med       Date:  2014-12-01       Impact factor: 21.405

Review 4.  Ischemic Stroke and Pulmonary Arteriovenous Malformations: A Review.

Authors:  Karan K Topiwala; Smit D Patel; Jeffrey L Saver; Christopher D Streib; Claire L Shovlin
Journal:  Neurology       Date:  2021-12-08       Impact factor: 9.910

5.  Right-to-left shunts in unexplained syncope: an age- and sex-matched case-control study.

Authors:  Dong Liu; Keyan Chen; Jie Gong; Lin Huang; Xin Dong; Qi Wan; Xiaoxuan Qin; Jiaojiao Shi; Lihong Zhang; Zhaolu Wang
Journal:  Quant Imaging Med Surg       Date:  2022-07

Review 6.  Pulmonary Arteriovenous Malformations: What the Interventional Radiologist Should Know.

Authors:  Claire S Kaufman; Jamie McDonald; Heather Balch; Kevin Whitehead
Journal:  Semin Intervent Radiol       Date:  2022-08-31       Impact factor: 1.780

7.  Stroke resulting from an isolated pulmonary arteriovenous malformation.

Authors:  Jakob Saidman; Hossam Abdou; Sridhar Sampath Kumar
Journal:  BMJ Case Rep       Date:  2017-10-10

8.  Pulmonary arteriovenous malformations may be the only clinical criterion present in genetically confirmed hereditary haemorrhagic telangiectasia.

Authors:  Emily Anderson; Lakshya Sharma; Ali Alsafi; Claire L Shovlin
Journal:  Thorax       Date:  2022-02-14       Impact factor: 9.102

9.  Hypoxaemia, sport and polycythaemia: a case from Imperial College London.

Authors:  Wakana Yasuda; James E Jackson; D Mark Layton; Claire L Shovlin
Journal:  Thorax       Date:  2015-04-08       Impact factor: 9.139

10.  Multiple strokes due to pulmonary arteriovenous malformation.

Authors:  Arsalan Talib Hashmi; Asiya Batool; Mazin O Khalid; Hitesh Raheja; Adnan Sadiq; Gerald Hollander
Journal:  Radiol Case Rep       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.